Management of Prolonged Uterine Bleeding in PCOS Without Current Medication
For a woman with PCOS experiencing prolonged uterine bleeding who is not on any medication, initiate combined hormonal contraceptives (CHCs) as first-line therapy to stabilize the endometrium and regulate menstrual cycles, while simultaneously ruling out underlying pathologic conditions such as pregnancy, thyroid disorders, and endometrial hyperplasia.
Initial Assessment and Exclusion of Pathology
Before initiating treatment, you must exclude underlying conditions that could explain the bleeding 1:
- Pregnancy testing - Essential first step
- Thyroid function - TSH level to rule out thyroid disease 2
- Prolactin level - Exclude hyperprolactinemia 2
- Endometrial evaluation - Consider endometrial biopsy or ultrasound, particularly given that PCOS significantly increases risk of endometrial hyperplasia (OR: 3.09) and endometrial cancer (OR: 6.98) in women with abnormal uterine bleeding 3
- STI screening - If sexually active
- Coagulation studies - If heavy bleeding or family history suggests bleeding disorder
First-Line Treatment: Combined Hormonal Contraceptives
CHCs are the recommended first-line treatment for menstrual irregularity in women with PCOS 4. Six clinical practice guidelines consistently support this approach for managing menstrual irregularity in adult women with PCOS 4.
Mechanism and Benefits:
- Suppresses ovarian androgen secretion
- Increases sex hormone-binding globulin levels
- Stabilizes the endometrium
- Reduces endometrial cancer risk (particularly important given PCOS-associated chronic anovulation) 2
- Addresses hyperandrogenic symptoms (acne, hirsutism) if present
Contraindications to Screen For:
Use the same screening criteria as for the general population:
- Blood pressure measurement required 5
- Smoking status and cardiovascular risk factors
- History of venous thromboembolism
- Migraine with aura
Alternative Hormonal Options
If CHCs are contraindicated or not desired 4:
Cyclic progestin therapy:
- Medroxyprogesterone acetate 10 mg daily for 10-14 days each month
- Induces regular withdrawal bleeding
- Protects endometrium from unopposed estrogen
- Three guidelines specifically recommend this for amenorrheic women with PCOS 4
Note: The optimal progestin type, duration, and frequency for endometrial cancer prevention in PCOS is not definitively established, but cyclic progestin is recommended 2.
Acute Bleeding Management (If Needed)
If the patient presents with acute heavy bleeding 1:
NSAIDs (5-7 days):
- Ibuprofen, mefenamic acid, or celecoxib
- Can be used while awaiting hormonal therapy to take effect
- Reduces menstrual blood loss through prostaglandin inhibition
For severe acute bleeding:
- High-dose estrogen therapy may be needed
- Consider hormonal treatment with low-dose COCs or estrogen for 10-20 days 1
Concurrent Lifestyle Intervention
Lifestyle modification is first-line intervention for PCOS itself 4, 6:
- Weight loss target: 5-10% if overweight/obese 4, 6
- Dietary approach: Calorie-restricted diet (500-700 kcal/day deficit), focus on low glycemic index foods 4
- Exercise: 150 minutes/week of moderate-high intensity aerobic exercise 4
- Behavioral interventions: Consider referral for structured behavioral therapy to enhance adherence 6
These lifestyle measures improve insulin resistance, which is central to PCOS pathophysiology, and may improve menstrual regularity independently.
Metabolic Screening
Given PCOS diagnosis, screen for associated metabolic complications 2:
- 2-hour oral glucose tolerance test with 75g glucose load - All women with PCOS should be screened for type 2 diabetes 2
- Fasting lipid panel - Total cholesterol, LDL, HDL, triglycerides 2
- Calculate BMI and waist-hip ratio 2
Follow-Up and Monitoring
- Advise the patient to return if bleeding persists or becomes unacceptable 5
- Reassess after 3-6 months of hormonal therapy
- If bleeding continues despite CHCs, consider:
- Adding NSAIDs during bleeding episodes 1
- Switching to different CHC formulation
- Re-evaluating for structural lesions (polyps, fibroids)
- Referral to gynecology if medical management fails
Critical Pitfall to Avoid
Do not delay endometrial assessment in women with PCOS and prolonged bleeding. PCOS-associated chronic anovulation creates prolonged unopposed estrogen exposure, substantially increasing endometrial hyperplasia and cancer risk 3. This is especially critical if the patient has additional risk factors such as obesity, age >35 years, or prolonged amenorrhea followed by heavy bleeding.